Arrowhead Pharmaceuticals, Inc. (ARWR) stock
ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Nov 12, 2026Score 5/3035% above fair value
$43.11+0.12 (+0.28%)
Close on Nov 18, 2026Market cap $6.09BP/E –Yield –
Arrowhead Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Arrowhead Pharmaceuticals's market cap was $6.97B on Nov 11, 2026, against $7.15B a year earlier. Over the last 5 years it ranged from $1.60B to $11.90B, with a median of $3.68B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $6.97B | -22.7% |
| 2025 | Dec 31, 2025 | $9.01B | +285.3% |
| 2024 | Dec 31, 2024 | $2.34B | -28.8% |
| 2023 | Dec 29, 2023 | $3.28B | -23.6% |
| 2022 | Dec 30, 2022 | $4.30B | -37.9% |
| 2021 | Dec 31, 2021 | $6.92B | -11.9% |
| 2020 | Dec 31, 2020 | $7.86B | +29.7% |
| 2019 | Dec 31, 2019 | $6.06B | +451.1% |
| 2018 | Dec 31, 2018 | $1.10B | +299.4% |
| 2017 | Dec 29, 2017 | $275.21M | +154.6% |
| 2016 | Dec 30, 2016 | $108.11M | -70.5% |
| 2015 | Dec 31, 2015 | $366.20M | -9.2% |
| 2014 | Dec 31, 2014 | $403.37M | +14.4% |
| 2013 | Dec 31, 2013 | $352.51M | +1113.1% |
| 2012 | Dec 31, 2012 | $29.06M | -19.8% |
| 2011 | Dec 30, 2011 | $36.21M | -43.6% |
| 2010 | Dec 31, 2010 | $64.19M | – |
See a number that looks wrong?